Doug Fairlie — ASN Events
  1. Schedule
  2. Doug Fairlie

Doug Fairlie

Olivia Newton-John Cancer Research Institute, VIC, Australia

  • This delegate is presenting an abstract at this event.
Doug Fairlie received his PhD from Monash University in 1994. Following postdoctoral stints in the US (State University of New York at Buffalo) and in Sydney (Centre for Immunology, St Vincent's Hospital), he moved to the Walter and Eliza Hall Institute where he is currently a Lab Head in the Structural Biology Division. His lab is interested in the molecular mechanisms underlying the Bcl-2 regulated pathways and uses a combination of biochemical, cell biology and structural biology techniques to better understand how cell death is regulated, and to create new tools including unnatural peptides that will help in the development of drugs for the treatment of cancer and helminth infections.
Presentations this author is a contributor to:

A novel mouse model to dissect the mechanisms of Bcl-2 regulated cell death in vivo (#428)

9:00 PM
Erinna Lee
Session Twelve - Poster Session D including Happy Hour & Trade Display

Flipping the life/death switch with non-natural peptide-based antagonists of the Bcl-2-regulated apoptosis pathway (#224)

8:45 PM
Doug Fairlie
Session Seven - Poster Session B Including Happy Hour & Trade Display

Mcl-1 and Bcl-xL can bind activated Bak to block apoptosis in response to BH3-only protein (#159)

4:00 PM
Colin Hockings
Session Five - Poster Session A including Refreshments